105832
NM_001161725.1
NM_001161726.1
NM_002719.3
NM_178586.2
NM_178587.2
XM_005267819.1
XM_005267820.1
XM_005267822.3
XM_005267823.1
XM_005267824.1
XM_005267826.1
XM_005267827.1
XM_011536914.2
XM_011536915.2
XM_011536916.2
XM_011536918.1
XM_011536919.2
XM_011536920.1
XM_011536921.2
XM_017021422.1
XM_017021423.1
XM_017021424.1
6%(+/-2% mRNA remaining)(HeLa cell line) [TaqMan® Assay ID: Hs00604902_m1]
HeLa cells were reverse transfected with 30 nM gene-specific siRNA or 30 nM Silencer® Negative Control #1 siRNA, using siPORT NeoFX Transfection Agent. 48 hours post-transfection, RNA was isolated, and then two-step qRT-PCR was performed using an appropriate TaqMan® Gene Expression Assay. 18S rRNA was used as an endogenous control. Validation results are expressed as average percent mRNA remaining, relative to Negative Control siRNA-treated samples, along with the standard deviation of multiple independent experiments.